Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma.
暂无分享，去创建一个
M. Gore | P. Hersey | A. Dalgleish | V. Cerundolo | P. Nathan | M. Millward | G. McArthur | I. Davis | R. Dunbar | J. Cebon | T. Evans | B. Smithers | E. Maraskovsky | Weisan Chen | W. Hopkins | J. Marsden | R. Venhaus | C. Ottensmeier | J. Thompson | Michael P. Findlay